SCHEMBL22010700

SCHEMBL22010700

CNc1cncc(C(C)(C)C)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
KDM4E B2RXH2 1/20 0.46
SLC22A12 Q96S37 2/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
SLC22A6 Q4U2R8 1/20 0.33
SLC22A8 Q8TCC7 1/20 0.33
SLC22A11 Q9NSA0 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
POLB P06746 1/20 0.33
HTT P42858 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
XDH P47989 1/20 0.32
TDO2 P48775 1/20 0.32
NAMPT P43490 1/20 0.32
EGFR P00533 2/20 0.32
ALPL P05186 1/20 0.31
TAS2R14 Q9NYV8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7665646 0.81 CYP3A4 (0.45) ALDH1A1KDM4ESLC22A12CYP3A4CYP2C9
Hydrochloric Acid SCHEMBL28527606 0.79 CYP3A4 (0.44) ALDH1A1KDM4ESLC22A12CYP3A4CYP2C9
SCHEMBL8049000 0.78 KDM4E (0.58) ALDH1A1KDM4EEGFR
SCHEMBL823824 0.78 GABRA1 (0.46) ALDH1A1KDM4EPOLBTDO2KIF11
SCHEMBL25755091 0.77 KIF11 (0.50) ALDH1A1KDM4ESLC22A12NPC1RAB9A
SCHEMBL13547852 0.75 ALDH1A1 (0.47) ALDH1A1KDM4ENPC1RAB9ACYP2C9
SCHEMBL12266458 0.75 PIK3CB (0.51) ALDH1A1SLC22A12CYP3A4CYP2C9SLC22A6
SCHEMBL14005522 0.75 XDH (0.42) KDM4ESLC22A12POLBXDHTDO2
SCHEMBL14005526 0.75 SLC22A12 (0.45) ALDH1A1SLC22A12NPC1RAB9ACYP3A4
SCHEMBL2739663 0.75 HCAR2 (0.40) SLC22A12CYP3A4POLBKIF11GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102098-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed